According to Omeros Corporation's latest financial reports and stock price the company's current number of shares outstanding is 62,856,721. At the end of 2023 the company had 62,856,721 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Year | Shares Outstanding | Change |
---|---|---|
2023 | 62.85 M | 0.15% |
2022 | 62.76 M | 0.34% |
2021 | 62.55 M | 1.45% |
2020 | 61.65 M | 21.8% |
2019 | 50.62 M | 3.29% |
2018 | 49.01 M | 2.04% |
2017 | 48.02 M | 11.19% |
2016 | 43.19 M | 13.71% |
2015 | 37.98 M | 11.4% |
2014 | 34.1 M | 14.26% |
2013 | 29.84 M | 15.29% |
2012 | 25.88 M | 16.36% |
2011 | 22.24 M | 3.53% |
2010 | 21.48 M | 633.27% |
2009 | 2.93 M | 0.71% |
2008 | 2.9 M |
Company | Shares Outstanding | differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | 2,407,200,000 | 3,729.66% | ๐บ๐ธ USA |
Pfizer PFE | 5,647,000,000 | 8,883.92% | ๐บ๐ธ USA |
Genetic Technologies GENE | 129,424 | -99.79% | ๐ฆ๐บ Australia |
Eterna Therapeutics ERNA | 5,410,000 | -91.39% | ๐บ๐ธ USA |